In late January 2026, Halozyme Therapeutics raised its 2025 and 2026 revenue guidance to about US$1.39 billion and up to US$1.81 billion, while outlining stronger multi‑year expectations backed by its ...
If you are asking whether Halozyme Therapeutics at around US$72.83 is offering good value or asking too much, you are exactly ...
Bluepoch Games introduces Beryl, a new 6-Star limited character, in its newly launched Parisian-themed A Flowing Feast update ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results